XML 29 R8.htm IDEA: XBRL DOCUMENT v3.20.1
Condensed Statements of Cash Flows - USD ($)
12 Months Ended
Dec. 31, 2019
Dec. 31, 2018
Dec. 31, 2017
Cash Flows from Operating Activities:      
Net income (loss) $ (8,143,415) $ (74,935,061) $ 28,605,741
Adjustments to reconcile net income (loss) to net cash provided by (used in) operating activities:      
(Increase) decrease in short-term investments 295,216 73,468,910 (73,764,126)
Unrealized (gain) loss on open futures contracts (17,876,577) 23,145,242 (5,699,448)
(Increase) decrease in receivable from Sponsor (16,330) 34,387 62,127
(Increase) decrease in dividends receivable (15,534) (11,339) 0
(Increase) decrease in interest receivable 4,320 10,558 (13,743)
(Increase) decrease in prepaid insurance 20,989 (35,750) (820)
(Increase) decrease in ETF transaction fees receivable (350) 700 (350)
Increase (decrease) in payable due to Broker 429,967 (442,429) 442,429
Increase (decrease) in management fees payable (226,413) 40,440 (117,011)
Increase (decrease) in professional fees payable (17,963) 20,887 (73,549)
Increase (decrease) in brokerage commissions payable (9,500) 0 (10,710)
Increase (decrease) in directors' fees and payable (7,540) 8,206 (128)
Net cash provided by (used in) operating activities (25,563,130) 21,304,751 (50,569,588)
Cash Flows from Financing Activities:      
Addition of shares 7,153,775 194,196,690 60,366,979
Redemption of shares (274,802,204) (160,352,516) (223,268,046)
Net cash provided by (used in) financing activities (267,648,429) 33,844,174 (162,901,067)
Net Increase (Decrease) in Cash and Cash Equivalents (293,211,559) 55,148,925 (213,470,655)
Total Cash, Cash Equivalents and Equity in Trading Accounts, beginning of period 490,625,457 435,476,532 648,947,187
Total Cash, Cash Equivalents and Equity in Trading Accounts, end of period 197,413,898 490,625,457 435,476,532
United States Commodity Index Fund      
Cash Flows from Operating Activities:      
Net income (loss) (8,413,932) (71,770,971) 26,490,920
Adjustments to reconcile net income (loss) to net cash provided by (used in) operating activities:      
(Increase) decrease in short-term investments 0 71,291,769 (71,291,769)
Unrealized (gain) loss on open futures contracts (16,626,852) 21,360,954 (4,817,510)
(Increase) decrease in dividends receivable (15,527) (9,983) 0
(Increase) decrease in interest receivable 4,224 9,374 (12,337)
(Increase) decrease in prepaid insurance 21,039 (35,991) (412)
(Increase) decrease in ETF transaction fees receivable (350) 350  
Increase (decrease) in management fees payable (224,947) 41,641 (119,158)
Increase (decrease) in professional fees payable (32,474) 64,879 (20,651)
Increase (decrease) in brokerage commissions payable (9,500) 0 (10,710)
Increase (decrease) in directors' fees and payable (7,506) 8,176 (256)
Net cash provided by (used in) operating activities (25,305,825) 20,960,198 (49,781,883)
Cash Flows from Financing Activities:      
Addition of shares 0 183,685,233 49,804,005
Redemption of shares (262,889,394) (152,234,093) (215,240,793)
Net cash provided by (used in) financing activities (262,889,394) 31,451,140 (165,436,788)
Net Increase (Decrease) in Cash and Cash Equivalents (288,195,219) 52,411,338 (215,218,671)
Total Cash, Cash Equivalents and Equity in Trading Accounts, beginning of period 478,509,213 426,097,875 641,316,546
Total Cash, Cash Equivalents and Equity in Trading Accounts, end of period 190,313,994 478,509,213 426,097,875
United States Copper Index Fund      
Cash Flows from Operating Activities:      
Net income (loss) 270,517 (2,992,568) 2,264,593
Adjustments to reconcile net income (loss) to net cash provided by (used in) operating activities:      
(Increase) decrease in short-term investments 295,216 1,880,591 (2,175,807)
Unrealized (gain) loss on open futures contracts (1,249,725) 1,785,413 (793,363)
(Increase) decrease in receivable from Sponsor (16,330) (11,146) 35,487
(Increase) decrease in dividends receivable (7) (1,356) 0
(Increase) decrease in interest receivable 96 915 (1,137)
(Increase) decrease in prepaid insurance (50) 19 (203)
(Increase) decrease in ETF transaction fees receivable 0 350 (350)
Increase (decrease) in payable due to Broker 429,967 (442,429) 442,429
Increase (decrease) in management fees payable (1,466) 831 2,244
Increase (decrease) in professional fees payable 14,511 885 (28,380)
Increase (decrease) in directors' fees and payable (34) 69 121
Net cash provided by (used in) operating activities (257,305) 221,574 (254,366)
Cash Flows from Financing Activities:      
Addition of shares 7,152,775 10,511,457 10,562,974
Redemption of shares (11,912,810) (6,538,962) (8,027,253)
Net cash provided by (used in) financing activities (4,760,035) 3,972,495 2,535,721
Net Increase (Decrease) in Cash and Cash Equivalents (5,017,340) 4,194,069 2,281,355
Total Cash, Cash Equivalents and Equity in Trading Accounts, beginning of period 12,116,244 7,922,175 5,640,820
Total Cash, Cash Equivalents and Equity in Trading Accounts, end of period 7,098,904 12,116,244 $ 7,922,175
USCF Crescent Crypto Index Fund      
Cash Flows from Operating Activities:      
Net income (loss) 0    
Cash Flows from Financing Activities:      
Addition of shares 1,000    
Redemption of shares 0    
Net cash provided by (used in) financing activities 1,000    
Net Increase (Decrease) in Cash and Cash Equivalents 1,000    
Total Cash, Cash Equivalents and Equity in Trading Accounts, beginning of period 0    
Total Cash, Cash Equivalents and Equity in Trading Accounts, end of period $ 1,000 $ 0